ÂÜÀòÂÒÂ×

Brenda L. has extensive experience in clinical research and global study management, particularly within oncology and other therapeutic areas. Currently serving as a Senior Study Manager at Pfizer since January 2018, Brenda leads Phase III oncology studies. Prior roles include Director at BNA Clinical Research Consulting Limited, overseeing chronic myelogenous leukemia studies in collaboration with Pfizer, and various positions at GSK, Novartis, Shire Pharmaceuticals, and Amgen, where responsibilities ranged from managing clinical trials to vendor selection and oversight. Brenda's education includes a Bachelor of Science with Honours in Microbiology from the University of Melbourne.